Probiotics and COVID-19
Probiotics boost the immune system, enhance the mucosal barrier function and inhibit bacterial adherence and invasion capacity in the intestinal epithelium by being in a direct antagonism with pathogenic bacteria. The gut-lung axis is involved in the pathogenicity of bacterial and viral infections, as the intestinal microbiota boosts the alveolar macrophage activity, thus having a protective role in host defense against pneumonia. Along these lines, current clinical evidence connects gut, lung, and brain as an entity with communication mediated through complex neural, immunologic inflammatory, and neuroendocrine networks, the so called gut-brain-lung axis. There are indications in animals and humans that intestinal microbiota provides bacteria to the lungs, as abundance of Bacteroides sp. is observed in the lung following sepsis. Moreover, following sepsis, neurologic and cognitive outcomes are observed. Without any doubt, the importance of the gut microbiome is stated. The composition of the gut microbiome may be used as a predictive tool of disease development and infection severity.
Related Conference of Probiotics and COVID-19
22nd International Conference on Virology, Emerging Diseases & vaccines
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
13th International Congress on Trauma, Critical Care and Emergency Medicine
Probiotics and COVID-19 Conference Speakers
Recommended Sessions
- Microbiome
- Pediatric and Infant Health
- Pre and Probiotics futures
- Prebiotics and Diet
- Prebiotics old and new
- Probiotics in Aquaculture
- Probiotics in food security
- Synbiotic
- Food and Fermentation
- Formulations and Production
- Gut Bacteria on COVID Severity
- Gut microbiota
- Microbiota from womb to adult
- Microbiota Protection and Resilience
- New Methods and New Equipment
- Nutrition and Probiotics
- Preterm and term Newborns Probiotics
- Probiotics and COVID-19
- Probiotics in oral health and dentistry
- Probiotics in women’s health
Related Journals
Are you interested in
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Critical Care Medicine - TRAUMA 2027 (France)
- Emergency Nursing and Trauma Care - TRAUMA 2027 (France)
- Ethics, Legal, and Policy Issues in Critical Care - TRAUMA 2027 (France)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Global Health and Trauma Care - TRAUMA 2027 (France)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric and Neonatal Emergency Care - TRAUMA 2027 (France)
- Resuscitation and Emergency Response - TRAUMA 2027 (France)
- Trauma and Emergency Medicine - TRAUMA 2027 (France)
- Trauma Imaging and Diagnostics - TRAUMA 2027 (France)
- Trauma Rehabilitation and Recovery - TRAUMA 2027 (France)
